Internal Medicine, Rheumatology · Yuma, AZ
NPI
1215939376
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2851 S Avenue B Bldg 20
Yuma, AZ, 85364
Phone (928) 336-2434
Groups this clinician bills Medicare through
Medicare paid, 2024
$82K
1,648 services
Medicare patients, 2024
628
Average age 73
Drug cost, 2024
$5.2M
12,554 prescriptions
Company payments, 2025
$69K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sherif Nasef was code 99214 (office e&m - established), 589 times for 352 patients. In total Sherif Nasef billed 1,648 services in 20 codes, and Medicare paid $82K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 589 | 352 | $63.33 | $37K |
| 99213 Office E&M - Established | Office | 352 | 265 | $41.25 | $15K |
| 20611 Joint Injection | Office | 212 | 87 | $53.73 | $11K |
| 99212 Office E&M - Established | Office | 130 | 44 | $25.73 | $3,345 |
| 20600 Joint Injection | Office | 93 | 38 | $18.67 | $1,736 |
| 99204 Office E&M - New | Office | 90 | 90 | $82.86 | $7,458 |
| 99203 Office E&M - New | Office | 71 | 71 | $54.15 | $3,845 |
| 20610 Joint Injection | Office | 21 | 18 | $36.40 | $764 |
| 20550 Musculoskeletal | Office | 20 | 11 | $23.11 | $462 |
| 20605 Joint Injection | Office | 16 | 13 | $20.31 | $325 |
By year: 2022 $97K for 1,766 services; 2023 $95K for 1,702 services; 2024 $82K for 1,648 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sherif Nasef prescribed most often to Medicare patients was Meloxicam, with 1,915 prescriptions and refills. In total Sherif Nasef wrote 12,554 Medicare prescriptions that cost $5.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Meloxicam Generic | 1,915 | 2,670 | 439 | $13K |
| Gabapentin Generic | 1,319 | 1,800 | 290 | $21K |
| Celecoxib Generic | 1,040 | 1,485 | 244 | $49K |
| Pregabalin Generic | 912 | 1,021 | 190 | $49K |
| Tramadol Hcl Generic | 908 | 910 | 211 | $10K |
| Duloxetine Hcl Generic | 781 | 1,381 | 179 | $21K |
| Diclofenac Sodium Generic | 697 | 759 | 246 | $36K |
| Hydroxychloroquine Sulfate Generic | 535 | 831 | 108 | $16K |
| Methotrexate Methotrexate Sodium | 421 | 606 | 79 | $7,336 |
| Cyclobenzaprine Hcl Generic | 386 | 444 | 90 | $4,885 |
| Tizanidine Hcl Generic | 362 | 547 | 88 | $6,143 |
| Humira(Cf) Pen Adalimumab | 220 | 227 | 27 | $1.9M |
| Zolpidem Tartrate Generic | 182 | 190 | 33 | $1,462 |
| Prednisone Generic | 166 | 240 | 48 | $963 |
| Leflunomide Generic | 156 | 287 | 40 | $12K |
Brand drugs: 807 claims; generic drugs: 11,747 claims; opioid claims: 1,039.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sherif Nasef $69K ($69K in general payments such as food, travel and fees) from 19 companies. The largest payer was UCB, Inc. with $67K.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 61 | $67K |
| Actelion Pharmaceuticals US, Inc. JNJ | 7 | $326 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $270 |
| Abbvie Inc. ABBV | 8 | $257 |
| Amgen Inc. AMGN | 7 | $226 |
| Merck Sharp & Dohme LLC MRK | 4 | $221 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $211 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $149 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $128 |
| Janssen Biotech, Inc. JNJ | 1 | $124 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.